[Effect of gangliosides on interferon-alpha activity].
1988
F N Voronina, and
N G Timofeeva, and
Ia E Khesin, and
V P Kuznetsov, and
L S Manakhova
UI
MeSH Term
Description
Entries
D007370
Interferon Type I
Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).
Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D002460
Cell Line
Established cell cultures that have the potential to propagate indefinitely.
Cell Lines,Line, Cell,Lines, Cell
D004351
Drug Resistance
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
Resistance, Drug
D005732
Gangliosides
A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997)
Ganglioside,Sialoglycosphingolipids
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
Related Publications
F N Voronina, and
N G Timofeeva, and
Ia E Khesin, and
V P Kuznetsov, and
L S Manakhova